JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Microbiology Section DOI : 10.7860/JCDR/2014/8772.4919
Year : 2014 | Month : Oct | Volume : 8 | Issue : 10 Full Version Page : DC01 - DC03

Urinary Tract Infection: Aetiology and Antimicrobial Resistance Pattern in Infants From A Tertiary Care Hospital in Northern India

Nirmaljit Kaur1, Shweta Sharma2, Shalini Malhotra3, Preeti Madan4, Charoo Hans5

1 Associate Professor, Department of Microbiology, PGIMER and Associated Dr. RML Hospital, New Delhi, India.
2 Senior Resident, Department of Microbiology, PGIMER and Associated Dr. RML Hospital, New Delhi, India.
3 Assistant Professor, Department of Microbiology, PGIMER and Associated Dr. RML Hospital, New Delhi, India.
4 Senior Medical Officer, Department of Microbiology, PGIMER and Associated Dr. RML Hospital, New Delhi, India.
5 Professor, Department of Microbiology, PGIMER and Associated Dr. RML Hospital, New Delhi, India.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Dr. Nirmaljit Kaur, Consulatant, Department of Microbiology, PGIMER and Associated Dr. RML Hospital, New Delhi, India. E-mail : njkbhatia@yahoo.co.in
Abstract

Introduction: Urinary tract infection (UTI) is one of the most common bacterial infections in childhood. Present study was undertaken to determine the occurrence of the uropathogens and their antimicrobial susceptibility pattern in infants (< 1yr) suspected with UTI.

Materials and Methods: This study was conducted in the Microbiology Department on urine samples received from infants for a period of two years from September 2011 to August 2013.

Results: Culture positivity rate was found to be 15.7%. There was an overall male preponderance in cases of UTI (70.1%). Most common bacterial isolate was E.coli (45.4%) followed by Klebsiella (16.7%) and Enterococcus spp (13.2%). Isolation of candida was 21.1%, maximum from ICU (63.1%). Maximum gram negative isolates (50%) showed high resistance to gentamicin, amikacin, cefotaxime and norfloxacin while most of the isolates (5%) were found susceptible to nitrofurantoin and piperacillin-tazobactam. 45.1% of gram negative bacilli were ESBL producer. We recommend continuous monitoring of changes in bacterial pathogens causing UTI and antibiotic sensitivity in each area for effective treatment of UTI.

Conclusion: Since antimicrobial resistance is a major problem, such study will help in formulating a strict antibiotics prescription policy in our country.

Keywords

Introduction

Urinary tract infection (UTI) is one of the most common bacterial infections in childhood. During the first year of life, the male-female ratio for UTI is 2.8-5.4: 1. Beyond 1-2 yr, there is a female preponderance, with a male: female ratio of 1: 10 [1]. UTI may involve only the lower urinary tract or may involve both the upper and lower tract. Paediatric urinary tract infections (UTI) are associated with high morbidity and long term complications like renal scarring, hypertension, and chronic renal failure [2]. It has been suggested that early diagnosis, proper investigation, adequate therapy and prolonged careful follow-up in children with UTI may well decrease the number of adults who present with chronic renal failure due to pyelonephritis [3]. Gram negative enteric bacilli, especially Escherichia coli and Klebsiella spp [1] are the leading pathogens, though Enterococcus spp., yeasts and Staphylococcus aureus have emerged as prominent agents in recent years [46]. Therapy for these children requires urine culture and appropriate antimicrobial sensitivity testing since many of the isolates were found to be multi-drug resistant [46]. There are very limited studies on infant UTI especially from India. Also micro-organisms isolated, present different susceptibility patterns to antimicrobial agents, which vary according to the place where the study is performed and also over time. Hence, this study was undertaken to determine the incidence of the urinary pathogens and their antimicrobial susceptibility pattern isolated from the urine samples from suspected urinary tract infections in infants (< 1yr) in a two yr period at a tertiary care hospital in Northern India.

Materials and Methods

This study was conducted in the Microbiology Department of Dr. Ram Manohar Lohia Hospital and PGIMER, New Delhi for a period of two yr from September 2011 to August 2013. All urine samples received from infants i.e. up to one yr age group and sent to microbiology laboratory were included in this study. Samples collected in unsterile containers as well as samples showing more than two isolates or mixtures were excluded from the study. For all cases, urine culture was done by semi-quantitative technique on 5% sheep Blood Agar and MacConkey Agar plates along with wet mount microscopy. Plates were incubated at 37°C overnight. Colony count was performed using standard technique for semi-quantitative culture of urine. Significant bacteriuria is defined as the bacterial count of 105 cfu/ml of a single type [7]. Various bacterial isolates were identified according to standard methods and tested against various antibiotics by Kirby Bauer’s disc diffusion method & zone diameters were interpreted according to the Clinical and Laboratory Standards Institute (CLSI) guidelines [8]. The antibiotics tested were Ampicillin (10μg), Gentamicin (10μg), Amikacin (30μg), Ciprofloxacin (5μg), Norfloxacin, Nalidixic acid, Nitrofurantoin, Ceftazidime (30μg), Amoxy-clavulanic acid, Piperacillin (100μg), Piperacillin-Tazobactam (100/10μg), Meropenem (10μg), Cefotaxime (30μg), high dose Gentamicin (120 μg), Cotrimoxazole(1.25/23.75μg), Vancomycin (30μg) & Linezolid (30μg) (Hi-Media Pvt. Laboratories, Bombay, India). Appropriate quality control strains were used to validate the results of the antimicrobial discs. ESBL production was determined by using phenotypic confirmatory test: Antibiotic disc of ceftazidime 30μg and ceftazidime- clavulanic acid 30/10μg, also cefotaxime 30μg and cefotaxime- clavulanic acid 30/10μg (HiMedia) were placed on inoculated MHA media 30mm apart from centre to centre and incubated at 37°C for 16-18 h. The zone of inhibition were recorded and difference in zone size of 5mm or more for either antimicrobial agents tested in combination with clavulanic acid versus its zone when tested alone were considered ESBL [8]. The same laboratory protocols were followed during the whole period. Any repeat isolate from the same patient obtained on more than one occasion was not included in the study.

Results

Total urine samples received in the laboratory in a two yr study period were 1108. Male: female ratio was found to be 3:2 with Ward: OPD: ICU ratio of 6.7:1.4:1.8 [Table/Fig-1]. 1108 urine samples were evaluated in the study, of which 174 (15.7%) children [144 male (70.1%), and 63 female (29.9%)] had culture proven UTI. There was an overall male preponderance in cases of UTI (70.1%) as shown in [Table/Fig-2]. Most common bacterial isolate was E.coli (45.4%) followed by Klebsiella (16.7%) and Enterococcus spp. (13.2%) out of 207 culture positive samples, candida was grown in 21.8% samples [Table/Fig-2]. 47.7% of the isolates were from ward patients followed by ICU (41.3%) and OPD (10.9%). Isolation of candida is maximum from patients admitted in ICU (63.1%) and wards (28.9%) [Table/Fig-2]. Maximum gram negative isolates (50%) showed high resistance to gentamicin, amikacin, cefotaxime and norfloxacin while most of the isolates (5%) were found susceptible to nitrofurantoin and piperacillin-tazobactam [Table/Fig-3]. 51 (45.1%) out of 113 gram negative bacilli were ESBL producer (Extended spectrum beta lactamase). All the gram negative bacilli were found sensitive to carbapenems. Enterococcus isolates were found susceptible to Vancomycin and Linezolid. [Table/Fig-3]

Age and area wise distribution of urine samples received

Age-groupsTotalMaleFemaleOPDWardICU
0-3 months267176914019829
3-6 months195110853812532
6-9 months15595602010233
9-12 months49129020161325105
Total1108671 (60.5%)437 (39.4%)159 (14.3%)750 (67.7%)199 (18%)

Age-wise and area-wise distribution of isolated organisms causing UTI

IsolatesTotal (%)0-1 m1-3 m*3-6 m6-9 m9-12 mArea-wise distribution
MFMFMFMFMFOPDWardICU
E.coli79 (45.4)31938373271574032
Klebsiella29 (16.7)213191-11014178
Enterococcus23 (13.2)1-224113545144
Acinetobacter3 (1.7)--------21-12
Pseudomonas2 (1.1)--------2---2
Candida38 (21.8)216263538231124
Total174 (15.7)28112781310542319 (10.9)83 (47.7)72 (41.3)

Antimicrobial resistance among isolated bacterial isolates

Antibiotic ResistanceE.coli n=79 (%)Klebsiella n=29 (%)Acineto-bacter n=3 (%)Pseudo-monas n=2 (%)Enteroc-occus n=23 (%)
A64 (81)22 (76)3 (100)2 (100)13 (57)
G42 (53)14 (48)3 (100)2 (100)-
Ak38 (48)12 (41)3 (100)2 (100)-
Nx60 (76)15 (52)3 (100)-18 (78)
Cf---2 (100)-
Na64 (81)16 (55)3 (100)--
Nf4 (5)5 (17)2 (67)04 (17)
Ce58 ((73)20 (69)3 (100)--
Ca58 (73)20 (69)3 (100)1 (50)-
Co59 (75)19 (69)3 (100)--
AC56 (71)18 (62)3 (100)--
Pc---0-
PT4 (5)01 (33)013 (57)
Mr0000-
Gh----18 (78)
Va----0
Lz----0
ESBL37 (47)13 (45)1 (33)--

*A- Ampicillin(10μg), G- Gentamicin(10μg), Ak- Amikacin(30μg), Cf-Ciprofloxacin(5μg), Nx- Norfloxacin, Na- Nalidixic acid, Nf- Nitrofurantoin, Ca-Ceftazidime(30μg), AC- Amoxy-clavulanic acid, Pc- Piperacillin(100μg), PT- Piperacillin-Tazobactam(100/10μg) , Mr- Meropenem(10μg) , Ce- Cefotaxime(30μg), Gh- high dose Gentamicin (120 μg), Co- Cotrimoxazole(1.25/23.75μg), Va- Vancomycin(30μg) & Lz- Linezolid(30μg)


Discussion

Our study describes the distribution and antibiotic susceptibility pattern of microbial species isolated from infant population with suspected UTIs in this hospital. In this study, 15.7% of the received samples were culture positive children. There was an overall male preponderance (70.1%) which is in accordance with other studies [9,10]. Therefore, male gender is a risk factor for UTI within one yr of age. Most common bacterial isolate was E.coli (38.2%) followed by Klebsiella and Enterococcus spp. The results of this study are in agreement with previous studies from India and other countries [1012] [Table/Fig-4]. Enterobacteriacae have several factors responsible for their attachment to the uroepithelium. These gram-negative aerobic bacteria colonise the urogenital mucosa with adhesin, pili, fimbriae and P1-blood group phenotype receptor [13]. In this study, Pseudomonas aeruginosa was isolated in two samples received from ICU and both the patients were catheterised. Lower UTI with Candida usually occurs with urinary catheters, typically after bacteriuria and antibiotic therapy. In our study, candida was grown in 38 (21.8%) positive samples, maximum from patients admitted in ICU (63.1%) and ward (28.9%).

Comparison of the present study with other related studies from India and neighbouring countries.

FeaturesPresent studyRasht, Iran [10]Chandigarh, India [2]Burdwan, India [18]
Age< 1 yr<2 yrs<12 yrs<12 yrs
SexMales>FemalesF>MM>FF>M
Common isolatesE.coli, Candida and KlebsiellaE.coli, KlebsiellaE.coli, Klebsiella and candidaE.coli, proteus and Klebsiella
Multi-drug resistance50%66%60-70%67-70%
ESBL45%Not doneNot doneNot done

Antibiotic resistance is a major clinical problem in treating infections caused by these microorganisms. The resistance to the antimicrobials has increased over the years. Resistance rates vary from country to country. Maximum gram negative isolates (50%) showed high resistance to gentamicin, amikacin, cefotaxime and norfloxacin while most of the isolates (5%) were found susceptible to nitrofurantoin and piperacillin-tazobactam, which is in accordance with other studies [11,12]. A possible cause of increased resistance might be widespread and inappropriate use of antibiotics. In this study, 51 out of 113 isolates of UTI pathogens (45.1%) were found to produce ESBL. This is consistent with other Indian studies (42%) [12]. 47 % of our E. coli isolates were ESBL producers, followed by 45% of K. pneumoniae. It might be possible that the high level of multi-drug resistance was most probably due to production of extended spectrum beta lactamases in these isolates [12,14,15]. To overcome this problem, unnecessary antibiotic therapy should be limited. It seems that the best choices for treatment of UTI in our region include nitrofurantoin and Piperacillin-tazobactam. In the present study, all the isolates were found to be sensitive to carbapenems (Meropenem). This is because carbapenem group is highly stable against β-lactamase and has an unusual property of causing a post antibiotic effect on gram-negative bacteria [16]. Due to its small molecular size it can overcome the poor permeability of β-lactams for Pseudomonas by efficient penetration through the porin, OMP-D [17].

To date, there is limited literature regarding the resistance of uropathogens to antibiotics in infants with UTIs. Hence, we recommend continuous monitoring of changes in bacterial pathogens causing UTI and antibiotic sensitivity in each area for effective treatment of urinary tract infections especially in infants. The goals of treatment of UTIs in infants are to eliminate the pathogen, to prevent urosepsis, and to reduce the risk of renal scarring.

Conclusion

It is quite alarming to note that most of the isolates included in this study were found resistant to four or more antibiotics. Antibiotic resistance is becoming major problem which threatens the lives of hospitalized individual and add considerably to health care cost. Therefore, it is an important issue to be addressed by the policy makers to formulate a strict antibiotics prescription policy in our country.

*A- Ampicillin(10μg), G- Gentamicin(10μg), Ak- Amikacin(30μg), Cf-Ciprofloxacin(5μg), Nx- Norfloxacin, Na- Nalidixic acid, Nf- Nitrofurantoin, Ca-Ceftazidime(30μg), AC- Amoxy-clavulanic acid, Pc- Piperacillin(100μg), PT- Piperacillin-Tazobactam(100/10μg) , Mr- Meropenem(10μg) , Ce- Cefotaxime(30μg), Gh- high dose Gentamicin (120 μg), Co- Cotrimoxazole(1.25/23.75μg), Va- Vancomycin(30μg) & Lz- Linezolid(30μg)

References

[1]Elder JS, Urinary tract infection. In: Kliegman, et al Nelson Text book of Pediatrics 2011 19th edPhiladelphiaSaunders:1829-34.  [Google Scholar]

[2]Taneja N, Chatterjee SS, Singh M, Singh S, Sharma M, Pediatric urinary tract infections in a tertiary care center from north India Indian J Med Res 2010 131:101-05.  [Google Scholar]

[3]Zorc JJ, Kiddoo DA, Shaw KN, Diagnosis and management of pediatric urinary tract infections Clin Microbiol Rev 2005 18:417-22.  [Google Scholar]

[4]Narasimhan KL, Chowdhary SK, Kaur B, Mittal BR, Bhattacharya A, Factors affecting renal scarring in posterior urethral valves J Pediatr Urol 2006 2:569-74.  [Google Scholar]

[5]Narasimhan KL, Mahajan JK, Kaur B, Mittal BR, The vesicoureteral reflux dysplasia syndrome in patients with posterior urethral valves J Urol 2005 174:1433-35.  [Google Scholar]

[6]Chandrasekharam VV, Srinivas M, Charles AR, Agarwala S, Mitra DK, Bal CS, Urinary-tract infection affects somatic growth in unilateral symptomatic hydronephrosis Pediatr Surg Int 2002 18:451-54.  [Google Scholar]

[7]Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. American Academy of Pediatrics. Committee on Quality Improvement. Subcommittee on Urinary Tract Infection Pediatrics 1999 103:843-52.  [Google Scholar]

[8]Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; Twentieth informational supplement. 2010;30 (1)M100–S20  [Google Scholar]

[9]Naseri M, Alamdaran A, Urinary tract infection and predisposing factors in children Iranian J Pediatr 2007 17:263-70.  [Google Scholar]

[10]Fatemeh A, Houman H, Masumeh S, Zahra A, Maryam RN, Morteza FK, Aetiologies and Antibiotic Resistance Patterns in Infants With Urinary Tract Infections Hospitalized in Children Medical Center Iranian J Neonatology 2013 4(2):21-25.  [Google Scholar]

[11]Akram M, Shahid M, Khan AU, Aetiology and antibiotic resistance patterns of community- acquired urinary tract infection in JNMC Hospital Aligarh. India Ann Clin Microbiol Antimicrob 2007 6:4  [Google Scholar]

[12]Sharma A, Shrestha S, Upadhyay S, Rijal P, Clinical and bacteriological profile of urinary tract infection in children at Nepal Medical College Teaching Hospital Nepal Med Coll J 2011 13(1):24-26.  [Google Scholar]

[13]Das RN, Chandrashekhar TS, Joshi HS, Gurung M, Shrestha N, Shivananda PG, Frequency and susceptibility profile of pathogens causing urinary tract infections at a tertiary care hospital in western Nepal Singapore Med J 2006 47(4):281  [Google Scholar]

[14]Grover SS, Sharma M, Chattopadhya D, Kapoor H, Pasha ST, Singh G, Phenotypic and genotypic detection of ESBL mediated cephalosporin resistance in Klebsiella pneumoniae: emergence of high resistance against cefepime, the fourth generation cephalosporin J Infect 2006 53(4):279-88.  [Google Scholar]

[15]Mohanty S, Singhal R, Sood S, Dhawan B, Das BK, Kapil A, Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against gram negative bacteria Indian J Med Res 2005 122(5):425-28.  [Google Scholar]

[16]Neu HC, Resistance of Pseudomonas aeruginosa to imipenem Infect Control Hosp Epidemiol 1992 13:7-9.  [Google Scholar]

[17]El Amin N, Giske CG, Jalal S, Keijser B, Kronvall G, Wretlind B, Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates APMIS 2005 113(3):187-96.  [Google Scholar]

[18]Choudhury P, Chaudhuri SN, Chattopadhyay C, Frequency of Urinary Tract Infections in Children and Antibacterial Resistance Pattern of Urinary Isolates in India International Journal of Pharmaceutical Science and Health Care 2013 2(3):37-41.  [Google Scholar]